Skip to main content
Premium Trial:

Request an Annual Quote

Myriad Genetics: Paul Bisaro

Myriad Genetics elected Paul M. Bisaro to its Board of Directors, effective immediately. Bisaro previously served as executive chairman of Amneal Pharmaceuticals and as president and CEO of Impax Laboratories, prior to its acquisition by Amneal. In addition to his new board position with Myriad, Bisaro currently serves as a director on the boards of Zoetis, TherapeuticsMD, and Mallinckrodt.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.